19-41354744-C-A

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BS1_SupportingBS2

The NM_030578.4(B9D2):​c.484G>T​(p.Gly162Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000052 in 1,614,004 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000054 ( 2 hom. )

Consequence

B9D2
NM_030578.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 0.0210
Variant links:
Genes affected
B9D2 (HGNC:28636): (B9 domain containing 2) This gene encodes a B9 domain protein, which are exclusively found in ciliated organisms. The gene is upregulated during mucociliary differentiation, and the encoded protein localizes to basal bodies and cilia. Disrupting expression of this gene results in ciliogenesis defects. [provided by RefSeq, Oct 2009]
TMEM91 (HGNC:32393): (transmembrane protein 91) Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be integral component of membrane. Predicted to be active in intracellular membrane-bounded organelle and membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.27533376).
BS1
Variant frequency is greater than expected in population afr. gnomad4_exome allele frequency = 0.000054 (79/1461694) while in subpopulation AFR AF= 0.00102 (34/33480). AF 95% confidence interval is 0.000746. There are 2 homozygotes in gnomad4_exome. There are 44 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
B9D2NM_030578.4 linkuse as main transcriptc.484G>T p.Gly162Cys missense_variant 4/4 ENST00000243578.8 NP_085055.2 Q9BPU9
B9D2XM_011527349.3 linkuse as main transcriptc.484G>T p.Gly162Cys missense_variant 4/4 XP_011525651.1 Q9BPU9
B9D2XM_011527350.3 linkuse as main transcriptc.325G>T p.Gly109Cys missense_variant 3/3 XP_011525652.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
B9D2ENST00000243578.8 linkuse as main transcriptc.484G>T p.Gly162Cys missense_variant 4/41 NM_030578.4 ENSP00000243578.2 Q9BPU9

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152192
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000638
AC:
16
AN:
250866
Hom.:
0
AF XY:
0.0000663
AC XY:
9
AN XY:
135746
show subpopulations
Gnomad AFR exome
AF:
0.0000617
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000529
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000540
AC:
79
AN:
1461694
Hom.:
2
Cov.:
32
AF XY:
0.0000605
AC XY:
44
AN XY:
727162
show subpopulations
Gnomad4 AFR exome
AF:
0.00102
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.0000188
Gnomad4 NFE exome
AF:
0.0000153
Gnomad4 OTH exome
AF:
0.000199
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152310
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.0000722
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000642
ExAC
AF:
0.0000988
AC:
12
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 25, 2024The c.484G>T (p.G162C) alteration is located in exon 4 (coding exon 3) of the B9D2 gene. This alteration results from a G to T substitution at nucleotide position 484, causing the glycine (G) at amino acid position 162 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 11, 2022Variant summary: B9D2 c.484G>T (p.Gly162Cys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 250866 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in B9D2 causing Joubert Syndrome And Related Disorders (6.4e-05 vs 0.0004), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.484G>T in individuals affected with Joubert Syndrome And Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJun 01, 2022This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 162 of the B9D2 protein (p.Gly162Cys). This variant is present in population databases (rs760322583, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with B9D2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1341710). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxFeb 15, 2022In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Meckel syndrome, type 10 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterJun 26, 2020The homozygous c.484G>T (p.Gly162Cys) variant identified in the B9D2 gene substitutes a moderately conserved Glycine for Cystine at amino acid 162/176 (exon 4/4). This variant is found with low frequency in gnomAD(v3.0) (3 heterozygotes, 0 homozygotes; allele frequency:2.09e-5) suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms do not agree on the effect of this variant, as it is predicted both Deleterious (Provean; score:-3.31) and Tolerated (SIFT; score:0.124) to the function of the canonical transcript. This variant is reported as a Variant of Uncertain Significance in ClinVar (VarID:329340) and to our current knowledge has not been reported in affected individuals in the literature. Given the lack of compelling evidence for its pathogenicity, the homozygous c.484G>T (p.Gly162Cys) variant identified in the B9D2 gene is reported here as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
6.9
DANN
Benign
0.94
DEOGEN2
Benign
0.26
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.57
T
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.28
T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
1.7
L
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-3.3
D
REVEL
Benign
0.14
Sift
Benign
0.12
T
Sift4G
Benign
0.13
T
Polyphen
0.0070
B
Vest4
0.24
MutPred
0.60
Loss of helix (P = 0.0558);
MVP
0.17
MPC
0.26
ClinPred
0.046
T
GERP RS
-0.68
Varity_R
0.41
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs760322583; hg19: chr19-41860649; API